Entrada Therapeutics Inc. (TRDA)
NASDAQ: TRDA
· Real-Time Price · USD
5.62
0.10 (1.81%)
At close: Aug 19, 2025, 3:06 PM
Entrada Therapeutics Revenue
Entrada Therapeutics reported an annual revenue of $210.78M, reflecting a 63.38% growth. For the quarter ending June 30, 2025, Entrada Therapeutics generated $1.95M in revenue.
Revenue (ttm)
210.78M
Revenue Growth
63.38%
Price / Sales Ratio
3.06
Revenue / Employee
1.15M
Employees
183
Market Cap
213.76M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 210.78M | +63.38% |
| Dec 31, 2023 | 129.01M | +Infinity% |
| Dec 31, 2022 | 0 | n/a |
| Dec 31, 2021 | 0 | n/a |
| Dec 31, 2020 | 0 | n/a |
| Dec 31, 2019 | 0 | n/a |